Helius Medical Technologies, Inc. Analyst EPS Estimates
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|---|---|---|---|
| Q1 2024 | 1 | -$5.04 | -$5.04 | -$5.04 |
| Q2 2024 | 1 | -$0.50 | -$0.50 | -$0.50 |
| Q3 2024 | 1 | -$1.06 | -$1.06 | -$1.06 |
| Q4 2024 | 1 | -$0.88 | -$0.88 | -$0.88 |
| Q1 2025 | 1 | -$0.88 | -$0.88 | -$0.88 |
| Q2 2025 | 1 | -$0.51 | -$0.51 | -$0.51 |
| Q3 2025 | 1 | -$0.52 | -$0.52 | -$0.52 |
| Q4 2025 | 1 | -$0.50 | -$0.50 | -$0.50 |
Helius Medical Technologies, Inc. Earnings Date And Information
Helius Medical Technologies, Inc. last posted its earnings results on Monday, August 12th, 2024. The company reported $-0.64 earnings per share for the quarter, missing analysts' consensus estimates of $-0.5 by $0.14. The company had revenue of 182,000 for the quarter and had revenue of 644,000 for the year. Helius Medical Technologies, Inc. has generated $-15 earnings per share over the last year ($-14.56 diluted earnings per share) and currently has a price-to-earnings ratio of -0.16. Helius Medical Technologies, Inc. has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, November 13th, 2024 based on prior year's report dates.
Helius Medical Technologies, Inc. Earnings History by Quarter
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 08/12/2024 | Q2 2024 | -$0.50 | -$0.64 | -0.14 | $150,000 | $182,000 |
| 05/13/2024 | Q1 2024 | -$3.87 | -$3.08 | 0.79 | $135,000 | |
| 03/28/2024 | Q4 2023 | -$4.05 | -$1.47 | 2.58 | $134,000 | |
| 11/09/2023 | Q3 2023 | -$6.00 | -$5.49 | 0.51 | $345,000 | $143,000 |
| 08/10/2023 | Q2 2023 | -$5.50 | -$2.92 | 2.58 | $188,333 | $256,000 |
| 05/11/2023 | Q1 2023 | -$5.00 | -$1.91 | 3.09 | $111,000 | |
| 03/09/2023 | Q4 2022 | -$5.50 | -$12.76 | -7.26 | $282,000 | |
| 11/14/2022 | Q3 2022 | -$12.00 | $8.32 | 20.32 | $167,500 | $196,000 |
| 08/15/2022 | Q2 2022 | -$1.12 | -$48.49 | -47.37 | $360,000 | $119,000 |
| 05/12/2022 | Q1 2022 | -$1.13 | -$51.75 | -50.62 | $190,000 | |
| 03/14/2022 | Q4 2021 | -$1.16 | -$65.60 | -64.44 | $258,000 | |
| 11/09/2021 | Q3 2021 | -$100.72 | $84,500 | $109,000 | ||
| 08/12/2021 | Q2 2021 | -$76.50 | -$129.05 | -52.55 | $95,000 | $71,000 |
| 05/17/2021 | Q1 2021 | -$61.00 | -$82.50 | -21.5 | $84,000 | |
| 03/10/2021 | Q4 2020 | -$88.57 | $191,000 | |||
| 11/12/2020 | Q3 2020 | -$157.34 | -$135.00 | 22.34 | $100,000 | $131,000 |
| 08/12/2020 | Q2 2020 | -$209.79 | -$145.00 | 64.79 | $100,000 | $133,000 |
| 05/11/2020 | Q1 2020 | -$269.00 | $207,000 | |||
| 03/12/2020 | Q4 2019 | -$367.13 | -$339.01 | 28.12 | $152,000 | |
| 11/12/2019 | Q3 2019 | -$384.62 | -$385.01 | -0.39 | $300,000 | $150,000 |
Helius Medical Technologies, Inc. Earnings: Frequently Asked Questions
-
When is Helius Medical Technologies, Inc.'s earnings date?
Helius Medical Technologies, Inc. has not confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, November 13th, 2024 based off last year's report dates.
-
How can I listen to Helius Medical Technologies, Inc.'s earnings conference call?
The conference call for Helius Medical Technologies, Inc.'s latest earnings report can be listened to online.
-
How can I read Helius Medical Technologies, Inc.'s conference call transcript?
The conference call transcript for Helius Medical Technologies, Inc.'s latest earnings report can be read online.
-
How much revenue does Helius Medical Technologies, Inc. generate each year?
Helius Medical Technologies, Inc. (:HSDT) has a recorded annual revenue of $644,000.
-
How much profit does Helius Medical Technologies, Inc. generate each year?
Helius Medical Technologies, Inc. (:HSDT) has a recorded net income of $644,000. Helius Medical Technologies, Inc. has generated $-14.56 earnings per share over the last four quarters.
-
What is Helius Medical Technologies, Inc.'s price-to-earnings ratio?
Helius Medical Technologies, Inc. (:HSDT) has a price-to-earnings ratio of -0.16 and price/earnings-to-growth ratio is -0.01.
